These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

793 related items for PubMed ID: 19833944

  • 21. US policy may encourage counterfeit drugs.
    Bouchie A.
    Nat Biotechnol; 2003 Feb; 21(2):121. PubMed ID: 12560826
    [No Abstract] [Full Text] [Related]

  • 22. Brand-name drug manufacturers risk antitrust violations by slowing generic production through patent layering.
    Paine CS.
    Seton Hall Law Rev; 2003 Feb; 33(2):479-510. PubMed ID: 12715807
    [No Abstract] [Full Text] [Related]

  • 23. Biotech patents-business as usual?
    Lawrence S.
    Nat Biotechnol; 2008 Dec; 26(12):1326. PubMed ID: 19060861
    [No Abstract] [Full Text] [Related]

  • 24. The ongoing regulation of generic drugs.
    Frank RG.
    N Engl J Med; 2007 Nov 15; 357(20):1993-6. PubMed ID: 18003956
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Using market-exclusivity incentives to promote pharmaceutical innovation.
    Kesselheim AS.
    N Engl J Med; 2010 Nov 04; 363(19):1855-62. PubMed ID: 21047231
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Delaying generic competition--corporate payoffs and the future of Plavix.
    Shuchman M.
    N Engl J Med; 2006 Sep 28; 355(13):1297-300. PubMed ID: 17005945
    [No Abstract] [Full Text] [Related]

  • 29. Branded drug reformulation: the next brand vs. generic antitrust battleground.
    Amoresano GV.
    Food Drug Law J; 2007 Sep 28; 62(1):249-56. PubMed ID: 17444032
    [No Abstract] [Full Text] [Related]

  • 30. Protect pharmaceutical innovation.
    Musselwhite LW, Andrews J.
    Science; 2010 Jun 11; 328(5984):1354; author reply 1354-5. PubMed ID: 20538934
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Drug patent protection: how long is long enough?
    Sibbald B.
    CMAJ; 2001 May 01; 164(9):1331. PubMed ID: 11341146
    [No Abstract] [Full Text] [Related]

  • 35. Should the patent system for new medicines be abolished?
    DiMasi JA, Grabowski HG.
    Clin Pharmacol Ther; 2007 Nov 01; 82(5):488-90. PubMed ID: 17952100
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. How Patent Troll Legislation Can Increase Timely Access to Generic Drugs.
    Treasure CL, Kesselheim AS.
    JAMA Intern Med; 2016 Jun 01; 176(6):729-30. PubMed ID: 27183456
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.